Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

10 August 2005

Late onset renal failure from angiotensin blockade (LORFFAB): a prospective thirty-month Mayo Health System clinic experience

Macaulay A C Onuigbo, Nnonyelum T C Onuigbo

Med Sci Monit 2005; 11(10): CR462-469 :: ID: 430303

Abstract

BACKGROUND: Worsening azotemia following initiation of angiotensin blockade(AB), in patients with CKD, RAS with/without precipitating factors is recognized. Small increases inserum creatinine following initiation of AB occur and must not warrant drug discontinuation. We anecdotallyhad observed improvement in CKD in patients with normal renal arteries and no precipitating factors,following termination of AB. The worldwide ESRD epidemic, coincident with increasing use of AB, promptedus to hypothesize a late-onset azotemia in such CKD patients. MATERIAL/METHODS: Over 30 months, 103 patientswith worsening azotemia, while on AB were evaluated. Ninety-seven patients with abnormal MRA and/or withprecipitating factors were excluded. In the remaining five, AB was discontinued, and GFR monitored. RESULTS:One male, four females, mean age 66.2 years. Three diabetic/hypertensives, one SLE/hypertensive, onediabetic/kidney transplant recipient. Mean stable AB, 25.2 months, (6-66 months). Mean follow up, 11.8months. One month following discontinuation of AB, GFR increased by a mean 45%. Mean serum creatininedecreased from 2.9+/-0.9 to 1.8+/-0.4 mg/dL (p=0.04). Uremic symptoms in 3, hyperkalemia in one, secondaryhyperparathyroidism in one, resolved. Two with anemia, now require less erythropoietin. CONCLUSIONS:We called this unrecognized potentially reversible late-onset worsening azotemia, occurring several monthsto years on stable AB, in CKD patients with normal renal arteries, without precipitating factors, late-onsetrenal failure from angiotensin blockade (LORFFAB). Pathophysiologically, the concept of microvascularRAS is invoked. The extent of LORFFAB, with millions of patients worldwide on AB, remains conjecturaland warrants further investigation.

Keywords: Angiotensin II Type 1 Receptor Blockers - adverse effects, Aged, 80 and over, angiotensin receptor antagonists, Angiotensin-Converting Enzyme Inhibitors - adverse effects, Blood Pressure, Creatinine - urine, Glomerular Filtration Rate, Kidney Failure, Chronic - urine, Prospective Studies, Uremia - physiopathology, Wisconsin

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750